Skip to main content
. 2022 Dec 15;109(11):823–831. doi: 10.1136/heartjnl-2022-321885

Figure 4.

Figure 4

Total (first and recurrent) HF hospitalisation and all-cause mortality in all patients regardless of EF (COMPASS-HF, CHAMPION, REDUCE-HF and GUIDE-HF). CHAMPION, CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in New York Heart Association Class III Heart Failure Patients; COMPASS-HF, Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure; D+L, DerSimonian and Laird; EF, ejection fraction; GUIDE-HF, Hemodynamic-Guided Management of Heart Failure; HF, heart failure; IHM, implantable haemodynamic monitor; I-V, inverse variance; LAPTOP-HF, Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy; REDUCE-HF, Reducing Events in Patients with Chronic Heart Failure.